Navamedic A Current Liabilities
The Current Liabilities of Navamedic A (NAVA.OL) as of Oct 9, 2026 is 90.63 M NOK. In the previous year, Current Liabilities was 220.98 M NOK — a change of -58.99% (lower).
Get this data via API
Financial Data API
Current Liabilities
90.63 MNOK
YoY
-58.99%
Last updated:
The Navamedic A Current Liabilities history
3 Years
10 Years
25 Years
Max
| YEAR | Current Liabilities | YoY |
|---|---|---|
| 90.63 MNOK | -58.99% | |
| 220.98 MNOK | -17.84% | |
| 268.96 MNOK | +96.55% | |
| 136.84 MNOK | -7.11% | |
| 147.31 MNOK | +45.84% | |
| 101.01 MNOK | +13.54% | |
| 88.96 MNOK | -25.08% | |
| 118.74 MNOK | +9.93% | |
| 108.02 MNOK | -40.78% | |
| 182.41 MNOK | +70.94% | |
| 106.71 MNOK | -10.14% | |
| 118.75 MNOK | +74.13% | |
| 68.20 MNOK | +157.16% | |
| 26.52 MNOK | -44.35% | |
| 47.65 MNOK | +330.28% | |
| 11.07 MNOK | -9.26% | |
| 12.20 MNOK | -62.14% | |
| 32.24 MNOK | -19.85% | |
| 40.22 MNOK | +518.88% | |
| 6.50 MNOK | +8.02% | |
| 6.02 MNOK | +233.69% | |
| 1.80 MNOK | +22.92% | |
| 1.47 MNOK | — |
Navamedic A Stock analysis
Frequently Asked Questions about Navamedic A stock
Current Liabilities of Navamedic A is 90.63 M NOK in 2025.
Current Liabilities of Navamedic A changed from 220.98 M NOK to 90.63 M NOK, representing a -58.99% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of Current Liabilities Navamedic A since 2006 – with annual values, charts, and detailed analysis.
Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.
Current Liabilities's NOK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Navamedic A historically and in real time.
Balance Sheet — Navamedic A
All Key Metrics — Navamedic A
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth